Agilent Technologies, Inc. $A Shares Sold by Primecap Management Co. CA

Primecap Management Co. CA lessened its stake in Agilent Technologies, Inc. (NYSE:A) by 7.7% during the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,412,706 shares of the medical research company’s stock after selling 118,450 shares during the quarter. Primecap Management Co. CA owned approximately 0.50% of Agilent Technologies worth $181,321,000 as of its most recent filing with the SEC.

Other hedge funds have also made changes to their positions in the company. Resona Asset Management Co. Ltd. boosted its position in shares of Agilent Technologies by 6.2% in the 2nd quarter. Resona Asset Management Co. Ltd. now owns 98,400 shares of the medical research company’s stock valued at $11,631,000 after purchasing an additional 5,767 shares during the period. CCLA Investment Management lifted its stake in shares of Agilent Technologies by 10.5% in the third quarter. CCLA Investment Management now owns 1,027,970 shares of the medical research company’s stock worth $131,909,000 after buying an additional 97,312 shares during the last quarter. Envestnet Asset Management Inc. boosted its stake in Agilent Technologies by 3.8% during the 3rd quarter. Envestnet Asset Management Inc. now owns 607,914 shares of the medical research company’s stock valued at $78,026,000 after purchasing an additional 22,498 shares during the period. Nuance Investments LLC increased its holdings in shares of Agilent Technologies by 13.5% during the 2nd quarter. Nuance Investments LLC now owns 80,698 shares of the medical research company’s stock worth $9,523,000 after purchasing an additional 9,628 shares during the period. Finally, Osaic Holdings Inc. raised its stake in shares of Agilent Technologies by 35.5% in the second quarter. Osaic Holdings Inc. now owns 68,053 shares of the medical research company’s stock valued at $8,017,000 after purchasing an additional 17,817 shares in the last quarter.

Agilent Technologies Trading Down 3.0%

Shares of A opened at $121.00 on Friday. The firm has a market cap of $34.22 billion, a P/E ratio of 26.71, a price-to-earnings-growth ratio of 3.62 and a beta of 1.30. Agilent Technologies, Inc. has a fifty-two week low of $96.43 and a fifty-two week high of $160.27. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.52 and a current ratio of 1.96. The business has a 50-day moving average of $134.99 and a 200 day moving average of $135.87.

Agilent Technologies (NYSE:A) last issued its quarterly earnings data on Wednesday, February 25th. The medical research company reported $1.36 EPS for the quarter, missing the consensus estimate of $1.37 by ($0.01). Agilent Technologies had a net margin of 18.26% and a return on equity of 24.95%. The firm had revenue of $1.80 billion for the quarter, compared to analysts’ expectations of $1.81 billion. During the same period in the prior year, the firm posted $1.31 EPS. Agilent Technologies’s revenue was up 7.0% on a year-over-year basis. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. As a group, research analysts forecast that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Agilent Technologies Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, April 22nd. Investors of record on Tuesday, March 31st will be paid a $0.255 dividend. The ex-dividend date of this dividend is Tuesday, March 31st. This represents a $1.02 annualized dividend and a dividend yield of 0.8%. Agilent Technologies’s dividend payout ratio (DPR) is presently 22.32%.

Agilent Technologies News Roundup

Here are the key news stories impacting Agilent Technologies this week:

• Positive Sentiment: Management set a FY‑26 revenue target of $7.3B–$7.5B and said it is expanding its “Ignite” operating system to drive margin improvement — a strategic signal that management expects revenue and margin expansion over the year. Agilent outlines $7.3B–$7.5B FY26 revenue target
• Positive Sentiment: Company-issued guidance: FY‑26 EPS range of 5.900–6.040 and Q2 EPS guidance roughly in-line with consensus, which provides a forward box for expectations and suggests management confidence despite a soft quarter. Agilent earnings/guidance details
• Neutral Sentiment: Top line growth remains positive — revenue rose about 7% YoY to ~$1.80B — but it narrowly missed some sell‑side estimates, leaving the print mixed from a growth standpoint. Agilent Q1 earnings/revenue recap
• Negative Sentiment: EPS missed consensus by $0.01 (reported $1.36 vs. ~$1.37 consensus) and revenue came in slightly below estimates; management cited a U.S. winter snowstorm that disrupted shipments and hurt margins — the immediate driver of the share decline. Agilent shares fall after Q1 earnings miss
• Negative Sentiment: Profitability and cash-flow signs were weak: operating profit and operating cash flow declined year-over-year, which raises near-term margin and free-cash-flow concerns for investors focused on quality of earnings. Q1 results: cash flow and profit weakness
• Negative Sentiment: Several brokers trimmed price targets (UBS, TD Cowen, Wells Fargo, Barclays) while largely maintaining buy/overweight ratings — a sign of reduced near‑term upside and caution among analysts despite longer‑term positive views. Analyst price target changes

Analysts Set New Price Targets

Several analysts have weighed in on the stock. Barclays decreased their price objective on shares of Agilent Technologies from $165.00 to $150.00 and set an “overweight” rating on the stock in a research note on Thursday. Citigroup boosted their price objective on shares of Agilent Technologies from $165.00 to $185.00 and gave the stock a “buy” rating in a research report on Tuesday, November 25th. Evercore raised shares of Agilent Technologies from an “in-line” rating to an “outperform” rating and upped their price target for the stock from $155.00 to $160.00 in a research report on Monday, January 5th. Wells Fargo & Company lowered their price target on shares of Agilent Technologies from $175.00 to $165.00 and set an “overweight” rating on the stock in a report on Thursday. Finally, The Goldman Sachs Group started coverage on shares of Agilent Technologies in a research report on Tuesday, December 9th. They issued a “buy” rating and a $170.00 target price for the company. Two analysts have rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $161.29.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.